Oncothyreon (ONTY) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Oncothyreon Reports First Quarter 2015 Financial Results
May 11, 2015 4:01 PM EDTSEATTLE, May 11, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq: ONTY) today reported financial results for the first quarter ended March 31, 2015.
Net loss for the three months ended March 31, 2015 was $7.9 million, or $0.08 per basic and diluted share, compared with a net loss of $9.6 million, or $0.14 per basic and diluted share, for the comparable period in 2014. The $1.7 million decrease in net loss was primarily attributable to the difference in the change in the fair value of warrant liability of $2.6 million offset by increases in research and development of $1.0 million.
As of March 31, 2015, Oncothyreon's cash, cash equivalents and... More



